CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy
Crossref DOI link: https://doi.org/10.1007/s13277-016-5301-x
Published Online: 2016-09-05
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Ming-Chung
Funding for this research was provided by:
National Science Council (NSC 101-2314-B-038-038)
License valid from 2016-09-05